Head-to-head · WeighScore
AgelessRx vs Ondra Health
By GLP-1 ScorecardUpdated
Score comparison
Ondra Health has the higher recorded score — 86.8/100 to 84.3/100.
Ondra Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Ondra publishes monthly and prepaid compounded injection plans with pharmacy choices; compare the upfront bill, eligible pharmacy and early-cancellation repricing before choosing a term.
Before you choose
AgelessRx does not publish a semaglutide price, so its AgelessRx review sets out what it does disclose, while the Ondra Health review explains the conditions attached to Ondra Health's figure. The semaglutide cost page compares published rates across the field. Ask AgelessRx for a written total before treating either one as the cheaper choice.
If neither one fits, AgelessRx vs PauseRX and AHBARx vs Ondra Health compare each of them with another graded program, and the list of alternatives to AgelessRx ranks the programs closest to AgelessRx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the yourEra review covers one graded close to these two, at 83.8/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | AgelessRx | Ondra Health |
|---|---|---|
| WeighScore | 84.3/100 | 86.8/100 |
| Grade | B | B |
| Site position | #17 | #5 |
| Semaglutide | Not verified (current medication-specific quote required) | $149/mo (compounded; month-to-month) |
| Tirzepatide | Microdose: $109 first month, then $318 every 2 months ($159/mo); full-dose quote required | $219/mo (compounded; month-to-month) |
| Coverage | Advertises US service; confirm treatment-specific state availability | Advertises 50 states; pharmacy and formulation eligibility varies |
| Brand-name access | Yes | Not confirmed |
| Oral / sublingual | Yes | Not confirmed |
Site position #17 · B
Strengths
- Conventional and lower-dose GLP-1 programs advertised
- Wegovy pens and oral-tablet consultations advertised
- Continuing messaging and check-ins advertised
What to consider
- Conventional medication-specific monthly quotes not verified
- Microdose introduction renews as a two-month charge
- Branded medication has a separate pharmacy bill
- Treatment-specific state eligibility and assigned dispenser need confirmation
Strengths
- Publishes monthly charges and separate upfront totals for longer plans
- Allows requests for an eligible pharmacy and formulation, subject to prescribing and availability
- Names independent clinical partners and advertises provider messaging, supplies and shipping
What to consider
- Six- and twelve-month plans require prepayment and an eligible Hallandale or Vials prescription
- Early prepaid cancellation reprices each three-month supply already sent at the regular quarterly rate
- Confirm the selected renewal cutoff and any earned consultation or administrative fees
- Branded and oral access, included lab testing and independent current certification were not established
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.